Breast Cancer Clinical Trial
Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients
Summary
This study is being done to find out if it is possible to enroll minority women with breast cancer in a study of how chemotherapy may affect their ability to answer certain questions and perform certain tasks that measure brain activity. The investigators want to look at thinking and brain activity in patients to see if cancer treatments can cause any brain changes. For this study, women without cancer, are being asked to participate in order to compare the answers to the questions and the brain wave activity measured in the women with cancer to women who don't have cancer.
Eligibility Criteria
Inclusion Criteria:
Is at least 18 years old, but not older than 61 years old;
Is female;
Is Hispanic of any race or Black/African American
Is fluent in English (see explanation in Section 7.0 Assessment / Evaluation Plan - Language Determination);
Has a diagnosis of breast cancer (Stage I-III);
Is treatment naïve and scheduled to receive chemotherapy, radiation, or endocrine therapy.
Healthy Control Subject Inclusion Criteria
Is at least 18 years old, but not older than 61 years old;
Is female;
Is Hispanic or Black Non-Hispanic;
Is fluent in English
Exclusion Criteria:
Participants with neurologic illnesses affecting cognition, (i.e., Traumatic Brain Injury with a loss of consciousness >30 min., etc.) or severe psychiatric illness (i.e., schizophrenia, bipolar disorder, etc.);
A hearing or visual deficit that impairs the ability to participate in the EEG tasks.
Any condition which prevents application of the 160 EEG electrodes spaced evenly across the participant's scalp, which includes dreadlocks, and hair extensions applied by weaving, braiding, gluing, or clips-. unless the participants are willing to undo these styles prior to the EEG.
Mini-Mental State Exam (MMSE) <16 (telephone version); MMSE <20 (in-person version)
Prior chemotherapy for any malignancy
Regularly taking opiates or take a daily, morning benzodiazepine or have taken a prn benzodiazepine prior to the assessment.
Healthy Control Subject Exclusion Criteria
Current or historical cancer diagnosis (a previous diagnosis of basal cell skin carcinoma is allowable)
History of neurologic illnesses affecting cognition, (i.e., Traumatic Brain Injury with a loss of consciousness >30 min., etc.) or severe psychiatric illness (i.e., schizophrenia, bipolar disorder, etc.);
A hearing or visual deficit that impairs the ability to participate in the EEG tasks.
Any condition which prevents application of the 160 EEG electrodes spaced evenly across the participant's scalp, which includes dreadlocks, and hair extensions applied by weaving, braiding, gluing, or clips-. unless the participants are willing to undo these styles prior to the EEG
Mini-Mental State Exam (MMSE) <16 (telephone version); MMSE <20 (in-person version)
Regularly taking opiates or takes a daily, morning benzodiazepine or has taken a prn benzodiazepine prior to the assessment.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Bronx New York, , United States
New York New York, 10021, United States
New York New York, , United States
New York New York, , United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.